Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors

NCT01999270 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Astrocytoma, Oligoastrocytoma, Mixed
Ganglioneuroma
Glioma
Ganglioglioma
Glioblastoma Multiforme Glioma

Interventions

DRUG: Irinotecan
DRUG: Bevacizumab
DEVICE: FDOPA-PET/MRI imaging

Sponsor

Washington University School of Medicine